Cigniti Wins “Best IoT Healthcare Platform” in the 2023 MedTech Breakthrough Awards Program
Dallas, USA, May 8, 2023: Cigniti Technologies, the world’s leading AI and IP-led Digital Assurance and Digital Engineering services company, has won the “Best IoT Healthcare Platform” award for its Internet of Medical Things (IoMT) Digital Quality Engineering Automation framework in the 7th annual MedTech Breakthrough Awards program. The prestigious MedTech Breakthrough Awards program recognizes outstanding digital health and medical technology products and companies, making this achievement a significant milestone.
Cigniti’s Internet of Medical Things (IoMT) Digital Quality Engineering Automation framework ensures wearables can predict and customize required medicine intake and deliver with precision while adhering to USFDA regulations. The Software as a Medical Device (SaMD) platform is wholly automated with minimal/no human intervention and capable of performing negative testing to ensure that the wearable delivers the intended results.
Speaking on this recognition, Cigniti’s CEO, Srikanth Chakkilam said, “We are proud to be at the forefront of the rapidly evolving Medical Devices industry, where IoMT and connected devices are becoming increasingly crucial to patient well-being and the digital transformation of clients. This award reaffirms Cigniti’s capabilities in this space and further strengthens our position in the market.”
Cigniti’s Chief Delivery Officer, Raghuram Krovvidy said, “In healthcare, patients’ lives are critical and therefore, the precision of connected devices is paramount. Cigniti’s Digital Quality Engineering framework winning the MedTech award is a recognition of the expertise and leadership in Digital Assurance services, especially Software as a Medical Device (SaMD) platforms.”
Cigniti’s world-class IoMT lab and infrastructure have helped a leading diabetes care provider, a medical devices company, and a leading healthcare company increase their cycle time, automation coverage, and time-to-market by 50% in compliance with stringent USFDA guidelines. This award recognizes Cigniti’s unwavering commitment to delivering industry-defining solutions to clients globally.